Valentina Paracchini
Overview
Explore the profile of Valentina Paracchini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Paracchini V, Petrillo M, Reiting R, Angers-Loustau A, Wahler D, Stolz A, et al.
Food Chem
. 2017 Apr;
230:681-689.
PMID: 28407967
Many food and feed additives result from fermentation of genetically modified (GM) microorganisms. For vitamin B2 (riboflavin), GM Bacillus subtilis production strains have been developed and are often used. The...
12.
Angers-Loustau A, Petrillo M, Paracchini V, Kagkli D, Rischitor P, Puertas Gallardo A, et al.
PLoS One
. 2016 Jan;
11(1):e0147692.
PMID: 26807711
Monitoring of the food chain to fight fraud and protect consumer health relies on the availability of methods to correctly identify the species present in samples, for which DNA barcoding...
13.
Ardissino G, Salardi S, Colombo E, Testa S, Borsa-Ghiringhelli N, Paglialonga F, et al.
Eur J Pediatr
. 2015 Oct;
175(4):465-73.
PMID: 26498648
Unlabelled: Despite the severity of HUS and the fact that it represents a leading cause of acute kidney injury in children, the general epidemiology of HUS is all but well...
14.
Carbone A, Castellani S, Favia M, Diana A, Paracchini V, Di Gioia S, et al.
J Cell Mol Med
. 2014 Jun;
18(8):1631-43.
PMID: 24894806
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, with most of the mortality given by the lung disease. Human amniotic mesenchymal stromal (stem)...
15.
Carbone A, Paracchini V, Castellani S, Di Gioia S, Seia M, Colombo C, et al.
Curr Stem Cell Res Ther
. 2013 Apr;
9(4):297-305.
PMID: 23597268
Lung diseases represent a significant burden of morbidity and mortality worldwide. Current therapies have not proven adequate in the long term and are often associated with significant side effects. There...
16.
Paracchini V, Seia M, Raimondi S, Costantino L, Capasso P, Porcaro L, et al.
JIMD Rep
. 2013 Feb;
4:17-23.
PMID: 23430892
The IRT screening test for the use in diagnosing newborns with CF has a high sensitivity but is not very specific resulting in a large number of screened positive infants...
17.
Costantino L, Rusconi D, Solda G, Seia M, Paracchini V, Porcaro L, et al.
Am J Respir Cell Mol Biol
. 2013 Jan;
48(5):619-25.
PMID: 23349053
Splicing mutations account for approximately 12% of the 1,890 cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations described in cystic fibrosis (CF). However, their impact on pre-mRNA processing frequently remains...
18.
Paracchini V, Carbone A, Colombo F, Castellani S, Mazzucchelli S, Di Gioia S, et al.
J Biomed Biotechnol
. 2012 Feb;
2012:575471.
PMID: 22315512
Cystic fibrosis (CF) is a monogenic disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, with lung and liver manifestations. Because of pitfalls of gene therapy, novel...
19.
Costantino L, Rusconi D, Claut L, Colombo C, Novara F, Paracchini V, et al.
J Cyst Fibros
. 2011 Aug;
10(6):412-7.
PMID: 21852204
Background: PCR-based diagnostic procedures are not able to characterise 6% of CF alleles. Recently, the application of array-CGH and of CFTR mRNA analysis has allowed the identification of new copy...
20.
Paffoni A, Paracchini V, Ferrari S, Scarduelli C, Seia M, Coviello D, et al.
J Assist Reprod Genet
. 2011 Mar;
28(5):461-70.
PMID: 21360136
Purpose: To develop an experimental model to assess the feasibility of polar body preimplantation genetic diagnosis without requiring oocyte fertilization. Methods: First polar body was removed from donated oocytes and...